Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Bevenopran (CB-5945) is a peripheral antagonist of μ-opioid receptor and can be used in studies about the treatment of opioid-induced bowel dysfunction.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 172.00 | |
5 mg | In stock | $ 388.00 | |
10 mg | In stock | $ 577.00 | |
25 mg | In stock | $ 926.00 | |
50 mg | In stock | $ 1,260.00 | |
100 mg | In stock | $ 1,680.00 | |
500 mg | In stock | $ 3,380.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 428.00 |
Description | Bevenopran (CB-5945) is a peripheral antagonist of μ-opioid receptor and can be used in studies about the treatment of opioid-induced bowel dysfunction. |
In vivo | Bevenopran tends to increase bowel movement (BM) frequency, especially for 0.1 mg twice daily and 4 mg daily, respectively[1]. |
Synonyms | CB-5945, ADL-5945 |
Molecular Weight | 386.44 |
Formula | C20H26N4O4 |
CAS No. | 676500-67-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 120 mg/mL (310.53 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Bevenopran 676500-67-7 Endocrinology/Hormones GPCR/G Protein Neuroscience Opioid Receptor CB-5945 Inhibitor ADL-5945 ADL 5945 CB 5945 inhibit ADL5945 CB5945 inhibitor